IL6 and myocardial ischemia: In patients with myocardial ischemia, especially in the acute phase, pro-inflammatory biological factors such as hsCRP, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) were significantly increased (23).